OP29: ST2+/IL-33 responsive cells promote tumorigenesis in colitis-associated colorectal cancer
ECCO '19 Copenhagen
2019
OP30: Serum proteomic profiling predicts and diagnoses pouchitis in ulcerative colitis patients undergoing ileal pouch-anal anastomosis
ECCO '19 Copenhagen
2019
OP31: TP53 mutation in human colonic organoids acquires resistance to in vitro long-term inflammation
ECCO '19 Copenhagen
2019
OP32: A novel mechanism of colonic epithelial-T-cell cross-talk is dysregulated in IBD
ECCO '19 Copenhagen
2019
OP33: BUB1: a new player in the development of Crohn’s disease (CD)-associated fibrosisECCO '19 Copenhagen
2019
1
OP34: VARSITY: A double-blind, double-dummy, randomised, controlled trial of vedolizumab versus adalimumab in patients with active ulcerative colitisECCO '19 Copenhagen
2019
OP35: Endoscopic and deep remission at 1 year prevents disease progression in early Crohn’s disease: long-term data from CALM
ECCO '19 Copenhagen
2019
OP36: A colonic gene expression signature predicts non-response to anti-inflammatory therapies in inflammatory bowel disease
ECCO '19 Copenhagen
2019
OP37: Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFI
ECCO '19 Copenhagen
2019
OP38: Maintenance treatment with mirikizumab, a p19-directed IL-23 antibody: 52-week results in patients with moderately-to-severely active ulcerative colitis
ECCO '19 Copenhagen
2019
P001: Multi-omic data integration assisted identification of molecular features contributing to disease heterogeneity in Crohn's disease
ECCO '19 Copenhagen
2019
P002: Endoscopic placement of a drug-eluting platform with monoclonal antibodies in an animal model of experimental colitis by TNBS: effect on disease outcome and anti-drug antibodies (ADA’s) formation
ECCO '19 Copenhagen
2019
P003: C86/CD16 macrophages may act as a source of WNT2b in intestinal tissue from B3 Crohn’s disease patients
ECCO '19 Copenhagen
2019
P004: IL-22 affects barrier function and cell polarity by MAPK/PI3 kinase signal transduction
ECCO '19 Copenhagen
2019
P005: Persistent transcriptional reprogramming in the choroid plexus during chronic colitis: towards understanding persistent fatigue in patients with quiescent inflammatory bowel disease?
ECCO '19 Copenhagen
2019
P006: Loss of protein tyrosine phosphatase non-receptor type 23 (PTPN23) in intestinal epithelial cells induces inflammation and epithelial hyperproliferation
ECCO '19 Copenhagen
2019
P007: Faecal protease activity as a predictor marker of disease recurrence in patients with Crohn's disease following ileocecectomy
ECCO '19 Copenhagen
2019
P008: Proteomic markers of response to anti-TNF drugs in patients with Crohn's disease
ECCO '19 Copenhagen
2019